BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34958911)

  • 1. Alterations in white matter fiber in Parkinson disease across different cognitive stages.
    Sang T; He J; Wang J; Zhang C; Zhou W; Zeng Q; Yuan Y; Yu L; Feng Y
    Neurosci Lett; 2022 Jan; 769():136424. PubMed ID: 34958911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing a diffusion tensor and non-tensor approach to white matter fiber tractography in chronic stroke.
    Auriat AM; Borich MR; Snow NJ; Wadden KP; Boyd LA
    Neuroimage Clin; 2015; 7():771-81. PubMed ID: 25844329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment.
    Pu W; Shen X; Huang M; Li Z; Zeng X; Wang R; Shen G; Yu H
    Curr Neurovasc Res; 2020; 17(4):480-486. PubMed ID: 32875986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.
    Chondrogiorgi M; Astrakas LG; Zikou AK; Weis L; Xydis VG; Antonini A; Argyropoulou MI; Konitsiotis S
    Brain Imaging Behav; 2019 Feb; 13(1):232-240. PubMed ID: 29629498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Li XR; Ren YD; Cao B; Huang XL
    Neurosci Lett; 2018 May; 675():127-132. PubMed ID: 29199095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of local white matter abnormality in Parkinson's disease by using an automatic fiber tract parcellation.
    Wang J; Zhang F; Zhao C; Zeng Q; He J; O'Donnell LJ; Feng Y
    Behav Brain Res; 2020 Sep; 394():112805. PubMed ID: 32673707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.
    Bledsoe IO; Stebbins GT; Merkitch D; Goldman JG
    Neurology; 2018 Dec; 91(24):e2244-e2255. PubMed ID: 30429273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter fiber-specific degeneration in older adults with metabolic syndrome.
    Andica C; Kamagata K; Uchida W; Takabayashi K; Shimoji K; Kaga H; Someya Y; Tamura Y; Kawamori R; Watada H; Hori M; Aoki S
    Mol Metab; 2022 Aug; 62():101527. PubMed ID: 35691528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved sensitivity to cerebral white matter abnormalities in Alzheimer's disease with spherical deconvolution based tractography.
    Reijmer YD; Leemans A; Heringa SM; Wielaard I; Jeurissen B; Koek HL; Biessels GJ;
    PLoS One; 2012; 7(8):e44074. PubMed ID: 22952880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter alterations and their associations with motor function in young adults born preterm with very low birth weight.
    Hollund IMH; Olsen A; Skranes J; Brubakk AM; Håberg AK; Eikenes L; Evensen KAI
    Neuroimage Clin; 2018; 17():241-250. PubMed ID: 29159041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Diffusion Tensor Imaging Study on White Matter Abnormalities in Patients with Type 2 Diabetes Using Tract-Based Spatial Statistics.
    Xiong Y; Sui Y; Xu Z; Zhang Q; Karaman MM; Cai K; Anderson TM; Zhu W; Wang J; Zhou XJ
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1462-9. PubMed ID: 26988810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis.
    Wei YC; Kung YC; Lin CP; Chen CK; Lin C; Tseng RY; Chen YL; Huang WY; Chen PY; Chong ST; Shyu YC; Chang WC; Yeh CH
    Behav Brain Funct; 2024 May; 20(1):12. PubMed ID: 38778325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local white matter abnormalities in Parkinson's disease with mild cognitive impairment: Assessed with neurite orientation dispersion and density imaging.
    Zhang C; Yuan Y; Sang T; Yu L; Yu Y; Liu X; Zhou W; Zeng Q; Wang J; Peng G; Feng Y
    J Neurosci Res; 2023 Jul; 101(7):1154-1169. PubMed ID: 36854050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the white matter neuronal integrity in amnestic mild cognitive impairment based on automating fiber-tract quantification].
    Li WP; Zhao H; Zhang X; Liang X; Liu Y; Zhang W; Zhang B
    Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):172-177. PubMed ID: 32008281
    [No Abstract]   [Full Text] [Related]  

  • 16. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
    Duncan GW; Firbank MJ; Yarnall AJ; Khoo TK; Brooks DJ; Barker RA; Burn DJ; O'Brien JT
    Mov Disord; 2016 Jan; 31(1):103-10. PubMed ID: 26202802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.
    Siasios I; Kapsalaki EZ; Fountas KN; Fotiadou A; Dorsch A; Vakharia K; Pollina J; Dimopoulos V
    Neurosurg Focus; 2016 Sep; 41(3):E12. PubMed ID: 27581308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Microstructural Differences between Essential Tremor and Parkinson Disease, Evaluated Using Advanced Diffusion MRI Biomarkers.
    Bergamino M; Aslam S; Knittel JJ; Alhilali L; Stokes AM
    J Integr Neurosci; 2023 Aug; 22(5):114. PubMed ID: 37735131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fixel-based analysis of white matter reductions early detects Parkinson disease with mild cognitive impairment.
    Liao TW; Wang JJ; Tsai CC; Wang PN; Chen YL; Wu YM; Wu YR
    Biomed J; 2023 Nov; ():100678. PubMed ID: 37949112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing white matter alterations subject to clinical laterality in drug-naïve de novo Parkinson's disease.
    Xiao Y; Peters TM; Khan AR
    Hum Brain Mapp; 2021 Oct; 42(14):4465-4477. PubMed ID: 34106502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.